Launch of Ceffibo tablet, which has strong antibacterial activity against resistant pneumococci.
KyungDong Pharm Co., Ltd. will release Ceffivo Tablets, a third-generation Cefem antibiotic, on December 1. The existing oral Cefem antibiotics are increasingly resistant to pneumococci and influenzae bacteria, but their effectiveness continues to decline.
Ceffivo tablets can be expected to have excellent antibacterial activity against these resistant strains, and are particularly effective against pneumococci and Haemophilus influenzae, which are the primary causes of respiratory and ENT infections.
In an effectiveness evaluation test targeting adults, the average effective rate was 84.9%, showing strong antibacterial activity, and it also showed a high effective rate in children, with an average of 95.6%.
In addition, the incidence of adverse reactions such as diarrhea, which frequently occurs with existing antibiotics, is low and mild, and it is a product that can be safely administered not only to adults but also to children with weak digestive systems.
♠ Product Information ♠
▷ Product name: Cefpibo tablets
▷ Ingredient content: Cefcapene pivoxil HCl 100㎎
▷ Effectiveness
- Superficial secondary infections such as folliculitis, nodules, furuncle, conjunctivitis, infectious impetigo, erysipelas, cellulitis, lymphangitis, epidermis, purulent gastritis, subcutaneous abscess, hidradenitis, infectious classification, mastitis, perianal abscess, trauma, laceration, surgical wound, etc.
- Pharyngitis, acute bronchitis, tonsillitis (peritonsillaritis, peritonsillar abscess), chronic bronchitis, bronchiectasis (in case of infection), secondary infection of chronic respiratory disease, pneumonia
- Pyelonephritis, cystitis, gonococcal urethritis
- Cholecystitis, cholangitis
- Adnexitis, intrauterine infection, cervicitis, Bartholin's adenitis
- Blepharitis, hordeorrhea, dacryocystitis, conjunctivitis, adenitis syrinx
- Otitis externa, otitis media, sinusitis
- Periodontitis, pericoronitis, mandibular inflammation
▷ Dosage and usage
- Adults: 100 mg 3 times a day after meals
- It increases or decreases appropriately depending on age and symptoms, but if it is intractable or the effect is insufficient, take 150 mg (potency) 3 times a day after meals.
▷ Insurance drug price: 412 won / fixed
▷ Insurance code: 648103080
▷ Packaging unit: 100 tablets
* For further details, please refer to the product manual.